These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38641163)

  • 1. Clinical feasibility of the preoperative C-reactive protein-albumin-lymphocyte index to predict short- and long-term outcomes of patients with gastric cancer.
    Okugawa Y; Ohi M; Kitajima T; Higashi K; Sato Y; Yamashita S; Uratani R; Shimura T; Imaoka H; Kawamura M; Koike Y; Yasuda H; Yoshiyama S; Okita Y; Toiyama Y
    J Gastrointest Surg; 2024 Jul; 28(7):1045-1050. PubMed ID: 38641163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the preoperative C-reactive protein-albumin-lymphocyte (CALLY) index on outcomes after gastrectomy for gastric cancer.
    Fukushima N; Masuda T; Tsuboi K; Takahashi K; Yuda M; Fujisaki M; Ikegami T; Yano F; Eto K
    Surg Today; 2024 Aug; 54(8):943-952. PubMed ID: 38491233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.
    Nakashima K; Haruki K; Kamada T; Takahashi J; Tsunematsu M; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
    Am Surg; 2024 Nov; 90(11):2703-2709. PubMed ID: 38644521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
    Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery.
    Takeda Y; Sugano H; Okamoto A; Nakano T; Shimoyama Y; Takada N; Imaizumi Y; Ohkuma M; Kosuge M; Eto K
    Asian J Surg; 2024 Aug; 47(8):3492-3498. PubMed ID: 38538400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
    Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
    In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]   [Full Text] [Related]  

  • 8. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
    Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
    Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer.
    Ma R; Okugawa Y; Shimura T; Yamashita S; Sato Y; Yin C; Uratani R; Kitajima T; Imaoka H; Kawamura M; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
    Surg Oncol; 2024 Apr; 53():102044. PubMed ID: 38335851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment.
    Melling N; Grüning A; Tachezy M; Nentwich M; Reeh M; Uzunoglu FG; Vashist YK; Izbicki JR; Bogoevski D
    Surgery; 2016 Jun; 159(6):1548-1556. PubMed ID: 26899471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer.
    Liu BZ; Tao L; Chen YZ; Li XZ; Dong YL; Ma YJ; Li SG; Li F; Zhang WJ
    PLoS One; 2016; 11(6):e0157401. PubMed ID: 27309531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.
    Yu L; Lv CY; Yuan AH; Chen W; Wu AW
    World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictive value of the CRP-albumin-lymphocyte index for prognosis of critically ill patients with sepsis in intensive care unit: a retrospective single-center observational study.
    Zhang J; Zhao Q; Liu S; Yuan N; Hu Z
    Front Public Health; 2024; 12():1395134. PubMed ID: 38841671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.
    Wu M; Pan Y; Jia Z; Wang Y; Yang N; Mu J; Zhou T; Guo Y; Jiang J; Cao X
    Dis Markers; 2019; 2019():9060845. PubMed ID: 31781312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer].
    Han BL; Wang YM; Xue YW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):65-70. PubMed ID: 31958933
    [No Abstract]   [Full Text] [Related]  

  • 19. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
    Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M
    Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
    Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
    Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.